The treatment of hepatitis C virus infections has taken a major step forward with the U.S. Food and Drug Administration’s approval of two new drugs, telaprevir and boceprevir, for managing the disease.
Go here to see the original:
Going Viral: New Hepatitis C Drugs Owe Their Success to HIV
If you enjoyed this post, make sure you subscribe to my RSS feed!